Denali Therapeutics (DNLI) Return on Assets (2018 - 2026)

Denali Therapeutics (DNLI) has 9 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Assets grew to 0.0% in Q1 2026 per DNLI's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q2 2023 and bottomed at 0.0% in Q4 2025.
• The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
• Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Tracing DNLI's Return on Assets over 5 years: stood at 0.0% in 2022, then jumped by 50 bps to 0.0% in 2023, then plunged by 146 bps to 0.0% in 2024, then slumped by 56 bps to 0.0% in 2025, then grew by 10 bps to 0.0% in 2026.
• Per Business Quant, the three latest DNLI Return on Assets figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison